Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.

Blood
Alexandra J GreenbergCeline M Vachon

Abstract

Monoclonal gammopathy of undetermined significance (MGUS), a precursor to multiple myeloma (MM), is one of the most common premalignant conditions in the general population. The cause of MGUS is largely unknown. Recent studies show that there is an increased prevalence of MGUS in blood relatives of persons with lymphoproliferative and plasma cell proliferative disorders, suggesting presence of shared underlying genetic influences. In the past few years, additional studies have examined risk factors and biologic characteristics that may contribute to the increased prevalence of MGUS among relatives of probands with MGUS, MM, and other blood malignancies. This article reviews the known epidemiology and risk factors for familial MGUS and myeloma, the risk of lymphoproliferative disorders and other malignancies among blood-relatives of patients with MGUS and MM, and discusses future directions for research.

References

Aug 1, 1985·Archives of Internal Medicine·L J HorwitzF Rosner
Jul 29, 1998·Clinical and Laboratory Haematology·P H RoddieA C Parker
Dec 19, 1998·British Journal of Haematology·H A DeshpandeP H Wiernik
Jun 3, 1999·British Journal of Haematology·B GrosboisR Bataille
Oct 5, 2001·Journal of the National Cancer Institute·H T LynchD D Weisenburger
Jul 9, 2002·British Journal of Haematology·Helga M OgmundsdóttirHrafn Tulinius
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Kari HemminkiKamila Czene
Apr 28, 2004·Cancer·Lynn R GoldinMartha S Linet
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry T LynchDennis Weisenburger
Jan 6, 2006·International Journal of Cancer. Journal International Du Cancer·Ola LandgrenLynn R Goldin
Mar 31, 2006·The New England Journal of Medicine·Robert A KyleL Joseph Melton
Sep 9, 2006·American Journal of Human Genetics·Mary L McMasterMargaret A Tucker
Sep 29, 2007·Human Molecular Genetics·Patrick J HaydenMark Lawler
Dec 7, 2007·Mayo Clinic Proceedings·Ola LandgrenS Vincent Rajkumar
Feb 21, 2008·Acta Haematologica·Seong-Ho KangDong Soon Lee
Jul 11, 2008·The New England Journal of Medicine·Henry T LynchStephan Thomé
Oct 17, 2008·The New England Journal of Medicine·Nicola J CampLisa A Cannon-Albright
Nov 28, 2008·American Journal of Hematology·Maneesh JainGeraldine P Schechter
Jan 7, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Brenda M BirmannGraham A Colditz
Jul 8, 2009·International Journal of Cancer. Journal International Du Cancer·Sigurdur Y KristinssonOla Landgren
Jul 22, 2009·Nature Genetics·Christine F SkibolaKevin M Brown
Jul 25, 2009·Blood·Henry T Lynch, Stephan D Thomé
Jan 1, 2007·Hereditary Cancer in Clinical Practice·Erica H GerkesEdo Vellenga
Jan 12, 2010·Nature Genetics·Dalemari Crowther-SwanepoelRichard S Houlston
Feb 5, 2010·The Lancet Oncology·Sandra GrassMichael Pfreundschuh
Jul 20, 2010·Nature Genetics·Lucia CondeChristine F Skibola
Jul 27, 2010·Hematological Oncology·Mark P PurdueDalsu Baris
Feb 24, 2011·European Journal of Haematology·Hlíf SteingrímsdóttirHelga M Ogmundsdóttir
Mar 25, 2011·Nature·Michael A ChapmanTodd R Golub
Aug 9, 2011·Urology·Phillip R CooperWilliam J Catalona

❮ Previous
Next ❯

Citations

Oct 1, 2013·Current Hematologic Malignancy Reports·Tommasina Guglielmelli, Antonio Palumbo
Nov 20, 2013·Leukemia·G J MorganR S Houlston
Sep 13, 2014·Hematology/oncology Clinics of North America·Robert A KyleS Vincent Rajkumar
Nov 26, 2015·Cancer Causes & Control : CCC·MaryAnn E VanValkenburgElizabeth E Brown
Apr 9, 2013·International Journal of Cancer. Journal International Du Cancer·Linda KachuriShelley A Harris
Apr 19, 2013·British Journal of Haematology·Maarten ArendsCarla E M Hollak
Oct 1, 2014·CA: a Cancer Journal for Clinicians·Giada Bianchi, Kenneth C Anderson
Mar 5, 2014·British Journal of Haematology·Alison S ThomasDerralynn A Hughes
Feb 14, 2015·International Journal of Cancer. Journal International Du Cancer·Frank NeumannBoris Kubuschok
Sep 18, 2012·Leukemia Research·Ulrich Germing, Andrea Kündgen
Sep 19, 2012·Leukemia Research·Torsten Haferlach
Aug 28, 2012·Leukemia Research·David P Steensma
Dec 7, 2013·Clinical Journal of Oncology Nursing·Pamela Rule, Jeannine M Brant
Dec 9, 2014·The Journal of Clinical Investigation·Klaus-Dieter PreussBoris Kubuschok
Mar 10, 2016·American Journal of Hematology·Ben BoursiYu-Xiao Yang
Sep 12, 2018·Leukemia·Alyssa I Clay-GilmourCeline M Vachon
Mar 28, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Shin-Ichiro FujiwaraYoshinobu Kanda
Aug 22, 2018·Journal of Clinical Medicine·Caterina LeddaVenerando Rapisarda
Nov 20, 2018·British Journal of Haematology·Klaus-Dieter PreussMichael Pfreundschuh
Feb 15, 2019·CA: a Cancer Journal for Clinicians·Carol E DeSantisRebecca L Siegel
Jan 9, 2021·Annals of Hematology·Maira A Castaneda-AvilaMara Meyer Epstein
Dec 29, 2020·Frontiers in Oncology·Lorenz ThurnerMoritz Bewarder
Dec 22, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Timothy Schmidt, Natalie Callander
Apr 21, 2021·Blood Cancer Journal·Laura Duran-LozanoBjörn Nilsson
Mar 23, 2021·Human Molecular Genetics·Rosalie Griffin WallerNicola J Camp
Jun 6, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qian-Yu LiHongmian Zhao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.